Evaluation of human epididymal secretory protein 4 expression according to the molecular subtypes (luminal A, luminal B, human epidermal growth factor receptor 2-positive, triple-negative) of breast cancer | Zendy

Gülden Diniz | Zendy; Gamze Aköz | Zendy; Sümeyye Ekmekçi | Zendy; Zübeyde Yıldırım Ekin | Zendy; Melek Ünçel | Zendy

Open Access

Evaluation of human epididymal secretory protein 4 expression according to the molecular subtypes (luminal A, luminal B, human epidermal growth factor receptor 2-positive, triple-negative) of breast cancer

Author(s) -

Gülden Diniz,

Gamze Aköz,

Sümeyye Ekmekçi,

Zübeyde Yıldırım Ekin,

Melek Ünçel

Publication year - 2018

Publication title -

indian journal of pathology and microbiology

Language(s) - English

Resource type - Journals

eISSN - 0974-5130

pISSN - 0377-4929

DOI - 10.4103/ijpm.ijpm_465_17

Subject(s) - epidermal growth factor receptor , human epidermal growth factor receptor 2 , triple negative breast cancer , cancer , cancer research , epidermal growth factor , breast cancer , human breast , receptor , biology , immunohistochemistry , medicine , endocrinology

Human epididymal secretory protein 4 (HE4) is originally described as an epididymis-specific protein but more recently suggested to be a putative serum tumor marker for some tumors, including breast carcinomas. In this study, we aimed to investigate the interactions between HE4 expression and molecular subtypes of breast carcinomas.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research